Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation
Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
To demonstrate that in patients with persistent atrial fibrillation who had recovered normal
sinus rhythm and treated with the best recommended therapies, the addition of 1 gram / daily
of n-3 PUFA is superior to the corresponding placebo for the maintenance of normal sinus
rhythm at one year of follow up.